A Diagnostics & Imaging Week

Grant Life Sciences (Salt Lake City) reported that it has received notice from the China Patent Office that it has granted the company Patent No. ZLO38150247.

In addition, the company said it has received notice from the U.S. Patent & Trademark Office that Patent No. 7,316,908 has been issued to it.

“While we are excited by both of these events, in particular this action by the Chinese government clears a path for us to move forward confidently as we seek a China-based development-and-commercialization partner for our serum-based test for cervical cancer in the largest market in the world,” said Hun-Chi Lin, PHD, Grant’s president and chief scientist, “and we fully expect that this Chinese patent will help us realize our goal of a Chinese partner.”

Grant Life Sciences is a development stage company that develops diagnostic kits for the screening, monitoring and diagnosis of diseases, with emphasis on women’s health, infectious diseases and cancers.